EurekaMag.com logo
+ Site Statistics
References:
53,214,146
Abstracts:
29,074,682
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on Google+Follow on Google+
Follow on LinkedInFollow on LinkedIn

+ Translate

Baseline characteristics of participants in phase I of the Trials of Hypertension Prevention






Annals of Epidemiology 2(3): 295-310

Baseline characteristics of participants in phase I of the Trials of Hypertension Prevention

Phase I of the Trials of Hypertension Prevention was designed to test the effectiveness and safety of three life-style (weight loss, sodium restriction, and stress management) and four nutrition supplement (calcium, magnesium, potassium, and fish oil) interventions in reducing diastolic blood pressure (DBP) in persons with a high-normal blood pressure. A total of 2182 persons with a DBP between 80 and 89 mm Hg met the eligibility criteria for participation in phase I and were randomized to one of the active intervention or control treatment groups. Most were white (82%), male (70%), married (76%), nonsmoking (88%), college graduate (53%), full-time employees (91%). The average blood pressure prior to entry into the trial was 124.9 mm Hg systolic and 83.8 mm Hg diastolic. A variety of baseline observations, including sociodemographic characteristics, personal and family medical history, health habits, diet, and biologic measurements, were documented before randomization and compared among the seven active intervention and control groups. As might be expected in a randomized trial of this sample size, the distribution of measured baseline characteristics was virtually identical in the treated and control groups. Based on this finding and the knowledge that randomization procedures were implemented without deviation from the phase I protocol, it is probable that unknown potential confounders were also equally distributed at entry into the study. Given the achievement of high rates of follow-up, subsequent differences in blood pressure are unlikely to have been due to baseline differences between the active treatment and control groups, and can probably be attributed to effects of the active interventions.

Accession: 002308363

PMID: 1342280

DOI: 10.1016/1047-2797(92)90062-U

Download PDF Full Text: Baseline characteristics of participants in phase I of the Trials of Hypertension Prevention



Related references

Baseline characteristics of participants in phase II of the trials of hypertension prevention (TOHP II). Annals of Epidemiology 5(2): 149-155, 1995

Baseline characteristics of participants in phase II of the Trials of Hypertension Prevention (TOHP II). Trials of Hypertension Prevention (TOHP) Collaborative Research Group. Annals of Epidemiology 5(2): 149-155, 1995

Design and baseline characteristics of participants in a phase III randomized trial of celecoxib and selenium for colorectal adenoma prevention. Cancer Prevention Research 5(12): 1381-1393, 2013

Systolic hypertension in the elderly program shep baseline characteristics of the randomized shep participants part 7 baseline laboratory characteristics. Hypertension (Dallas) 17(3 SUPPL 2): II102-II122, 1991

Systolic hypertension in the elderly program shep baseline characteristics of the randomized shep participants part 6 baseline physical examination findings. Hypertension (Dallas) 17(3 SUPPL 2): II77-II101, 1991

Systolic hypertension in the elderly program shep baseline characteristics of the randomized shep participants part 4 baseline medical history findings. Hypertension (Dallas) 17(3 SUPPL 2): II35-II61, 1991

Recruitment for phase II of the Trials of Hypertension Prevention. Effective strategies and predictors of randomization. Trials of Hypertension Prevention (TOHP) Collaborative Research Group. Annals of Epidemiology 5(2): 140-148, 1995

Systolic hypertension in the elderly program shep baseline characteristics of the randomized shep participants part 5 baseline blood pressure and pulse rate measurements. Hypertension (Dallas) 17(3 SUPPL 2): II62-II76, 1991

Trials of Hypertension Prevention, phase II. Structure and content of the weight loss and dietary sodium reduction interventions. Trials of Hypertension Prevention (TOHP) Collaborative Research Group. Annals of Epidemiology 5(2): 156-164, 1995

Efficacy of nonpharmacologic interventions in adults with high-normal blood pressure: results from phase 1 of the Trials of Hypertension Prevention. Trials of Hypertension Prevention Collaborative Research Group. American Journal of Clinical Nutrition 65(2 Suppl): 652s-660s, 1997